The latest happenings of the industry from the past month.
WCG announced that Carsten Henke has joined the company as Senior Vice President, Europe and Managing Director, Germany.
Former Chief Commercial Officer, Jeremy Edwards, has been appointed CEO of Raremark and former Head of Product, Alex Garner, has become COO.
ActiGraph announced the hiring of Kuno van der Post as Chief Commercial Officer, Lynda Barr as Chief Financial Officer, and Scott Ginnetti as Vice President of Human Resources and Culture.
Medable Inc announced several new hires including Mary Costello as Head of Site and Investigator Network, Rasmus Hogreffe as VP of Decentralized Trial Innovation, Steve Lesser as VP of Partner Strategy, Heidi Pfefferkorn as Decentralized Solutions Leader, Eric Peper as Executive VP of Sales, David Swanger as Senior VP of Marketing, and Ching Tian as Senior VP of Strategy & Solutions.
Veeva Systems announced that more than 500 in over 30 countries are using Veeva SiteVault Free.
Oracle Health Sciences, for the 4th year in a row, has been named a “Leader” in the Everest Group Clinical Development Platforms Products PEAK Matrix Assessment 2020. Oracle also maintained its position as the highest positioned vendor in “Vision and Capability” and took the highest position for “Market Impact.”
Syneos Health announced that it was awarded the Society for Clinical Research Sites (SCRS) Eagle Award, for the fourth consecutive year.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Unlock Commercial Growth through Data-Driven Patient and HCP Insights
May 2nd 2025Leveraging data-driven patient and healthcare provider (HCP) insights, including social drivers of health (SDOH), is essential for life sciences companies to continuously improve patient engagement and commercial success. Mark Rodgers, AVP of Commercial Analytics at Inovalon, discusses how identifying treatment milestones, assessing HCP performance, and segmenting patient populations using SDOH data can drive targeted strategies that improve healthcare outcomes and market access